These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19374968)

  • 1. What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia?
    Mazza M; Mazza O; Pomponi M; Di Nicola M; Padua L; Vicini M; Bria P; Mazza S
    Compr Psychiatry; 2009; 50(3):240-4. PubMed ID: 19374968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of serotonergic antidepressant therapy on temperament and character scales in patients with chronic tension-type headache.
    Boz C; Gazioglu S; Altunayoglu V; Hocaoglu C
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):534-42. PubMed ID: 17875033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pharmacological treatment on temperament and character in panic disorder.
    Marchesi C; De Panfilis C; Cantoni A; Giannelli MR; Maggini C
    Psychiatry Res; 2008 Mar; 158(2):147-54. PubMed ID: 18234355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol.
    Tome MB; Cloninger CR; Watson JP; Isaac MT
    J Affect Disord; 1997 Jul; 44(2-3):101-9. PubMed ID: 9241570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temperament and character profile of patients with fibromyalgia.
    Gencay-Can A; Can SS
    Rheumatol Int; 2012 Dec; 32(12):3957-61. PubMed ID: 22200811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
    Walitt B; Urrútia G; Nishishinya MB; Cantrell SE; Häuser W
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011735. PubMed ID: 26046493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger].
    Pelissolo A; Corruble E
    Encephale; 2002; 28(4):363-73. PubMed ID: 12232546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the Temperament and Character Inventory dimensions after paroxetine treatment in patients with major depressive disorder.
    Tomita T; Kaneda A; Nakagami T; Kaneko S; Yasui-Furukori N
    Hum Psychopharmacol; 2015 Sep; 30(5):334-40. PubMed ID: 25845342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of personality factors on paroxetine response time in patients with major depression.
    Kaneda A; Yasui-Furukori N; Nakagami T; Sato Y; Kaneko S
    J Affect Disord; 2011 Dec; 135(1-3):321-5. PubMed ID: 21784533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic mechanism of antidepressant action in depressed patients.
    Willner P; Hale AS; Argyropoulos S
    J Affect Disord; 2005 May; 86(1):37-45. PubMed ID: 15820269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.
    Shih YC; Bekele NB; Xu Y
    Pharmacoeconomics; 2007; 25(10):843-62. PubMed ID: 17887806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of personality by serotonergic intervention.
    Balon R
    Am J Psychiatry; 1999 Jun; 156(6):985. PubMed ID: 10360169
    [No Abstract]   [Full Text] [Related]  

  • 13. Paresthesia frequency in fibromyalgia and its effects on personality traits.
    Balbaloglu O; Tanik N; Alpayci M; Ak H; Karaahmet E; Inan LE
    Int J Rheum Dis; 2018 Jul; 21(7):1343-1349. PubMed ID: 29968325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic efficacy of fluoxetine, escitalopram, sertraline, paroxetine, and concomitant psychotherapy in major depressive disorder: outcome after long-term follow-up.
    Peselow ED; Tobia G; Karamians R; Pizano D; IsHak WW
    Psychiatry Res; 2015 Feb; 225(3):680-6. PubMed ID: 25496869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloninger's psychobiological model of personality and psychological distress in fibromyalgia.
    Garcia-Fontanals A; García-Blanco S; Portell M; Pujol J; Poca-Dias V; García-Fructuoso F; López-Ruiz M; Gutiérrez-Rosado T; Gomà-I-Freixanet M; Deus J
    Int J Rheum Dis; 2016 Sep; 19(9):852-63. PubMed ID: 25483854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personality change during depression treatment: a placebo-controlled trial.
    Tang TZ; DeRubeis RJ; Hollon SD; Amsterdam J; Shelton R; Schalet B
    Arch Gen Psychiatry; 2009 Dec; 66(12):1322-30. PubMed ID: 19996037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using secondary binding properties to select a not so selective serotonin reuptake inhibitor.
    Stahl SM
    J Clin Psychiatry; 1998 Dec; 59(12):642-3. PubMed ID: 9921697
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
    Sanchez C; Reines EH; Montgomery SA
    Int Clin Psychopharmacol; 2014 Jul; 29(4):185-96. PubMed ID: 24424469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.